Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease

Elisa K. Boden,Donna M. Shows,Michael V. Chiorean,James D. Lord

Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease

2018

Elisa K. Boden
Donna M. Shows
Michael V. Chiorean
James D. Lord

Background/Aims Vedolizumab is an anti-α4β7 monoclonal antibody approved for the treatment of inflammatory bowel disease (IBD). This exploratory study aimed to identify biomarkers associated with vedolizumab response.

Keywords:

Endocrinology
Internal medicine
Personalized medicine
Immunology
Medicine
Monoclonal antibody
Biomarker (medicine)
Vedolizumab
Inflammatory bowel disease
Oncology
Gastrointestinal agent
treatment outcome
Hepatology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations